Eagle Claw Capital Managment, LLC Bristol Myers Squibb CO Transaction History

Eagle Claw Capital Managment, LLC

$538 Million
Q1 2024

A detailed history of Eagle Claw Capital Managment, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 59,368 shares of BMY stock, worth $2.4 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

59,368

Previous 58,232 1.95%

Holding current value

$2.4 Million

Previous $2.99 Million 7.77%

% of portfolio

0.6%

Previous 0.64%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $54,505 - $61,798	1,136 Added 1.95%	59,368 $3.22 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $401,172 - $478,708	-8,275 Reduced 12.44%	58,232 $2.99 Million
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $72,362 - $80,912	1,250 Added 1.92%	66,507 $3.86 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $4,778 - $5,305	75 Added 0.12%	65,257 $4.17 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $12,484 - $14,160	-190 Reduced 0.29%	65,182 $4.52 Million

Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $164,352 - $194,616	2,400 Added 3.81%	65,372 $4.7 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $157,504 - $186,507	-2,300 Reduced 3.52%	62,972 $4.53 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $273 - $161,364	2,100 Added 3.32%	65,272 $4.64 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $181,550 - $199,950	-2,500 Reduced 3.81%	63,172 $4.86 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $36,888 - $44,232	-600 Reduced 0.91%	65,672 $4.8 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $97,874 - $114,099	1,825 Added 2.83%	66,272 $4.13 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $106,506 - $124,758	1,800 Added 2.87%	64,447 $3.81 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $235,258 - $256,196	3,800 Added 6.46%	62,647 $4.19 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $427,841 - $481,195	7,210 Added 13.96%	58,847 $3.72 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $11,548 - $13,086	200 Added 0.39%	51,637 $3.21 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $212,778 - $235,786	3,705 Added 7.76%	51,437 $3.1 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $82,230 - $96,135	-1,500 Reduced 3.05%	47,732 $2.82 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $66,120 - $96,087	1,425 Added 2.98%	49,232 $2.75 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $695,091 - $906,683	14,125 Added 41.94%	47,807 $3.07 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $915,064 - $1.08 Million	21,395 Added 174.13%	33,682 $1.7 Million
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $74,292 - $82,151	1,665 Added 15.68%	12,287 $557,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $11,038 - $12,450	200 Added 1.92%	10,622 $658,000
Q1 2018 May 18, 2018	BUY	$59.92 - $68.98 $11,984 - $13,796	200 Added 1.96%	10,422 $659,000
Q2 2017 Aug 15, 2017	BUY	N/A	10,222	10,222 $570,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.

Account

Eagle Claw Capital Managment, LLC Bristol Myers Squibb CO Transaction History